Medtronic bankrolls drug-device trial for Nile Therapeutics heart failure treatment March 1, 2011 By drugdelivery Medtronic Inc. (NYSE:MDT) will fund a clinical trial for Nile Therapeutics Inc. (NSDQ:NLTX) behind a peptide treatment for heart failure.
